Peripheral neuropathy associated with topical tretinoin therapy

[1]  D. Reinhardt,et al.  Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. , 2003, Medical and pediatric oncology.

[2]  W. Cunliffe,et al.  Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. , 2002, European journal of dermatology : EJD.

[3]  M. Smith,et al.  Where to next with retinoids for cancer therapy? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  T. Schroeter,et al.  Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia. , 2000, Medical and pediatric oncology.

[5]  O. Mills,et al.  Irritation potential of a new topical tretinoin formulation and a commercially-available tretinoin formulation as measured by patch testing in human subjects. , 1998, Journal of American Academy of Dermatology.

[6]  Y. Miura,et al.  Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management. , 1997, International journal of hematology.

[7]  A. Bernstein,et al.  Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A) , 1996, Annals of Internal Medicine.

[8]  N. Komatsu,et al.  Toxicity of tretinoin in acute promyelocytic leukaemia , 1994, The Lancet.

[9]  H. Biesalski.  Comparative assessment of the toxicology of vitamin A and retinoids in man. , 1989, Toxicology.

[10]  R. H. Spector,et al.  Pseudotumor cerebri caused by a synthetic vitamin A preparation , 1984, Neurology.

[11]  T. Nigra,et al.  General clinical toxicology of oral retinoids. , 1982, Journal of the American Academy of Dermatology.

[12]  S. Tura,et al.  All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. , 1996, Haematologica.